EUVIMEDEUVIMED entdecken
Open Access

Second-Order Effects of Chemotherapy Pharmacodynamics and Pharmacokinetics on Tumor Regression and Cachexia

Luke Pierik, Patricia McDonald, Alexander R A Anderson, Jeffrey West iD

Bulletin of Mathematical Biology · 2024-05 · 86 (5)

DOI: 10.1007/s11538-024-01278-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bulletin of Mathematical Biology, online erschienen am 28.03.2024. Verfasst von Luke Pierik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Complex Biological Systems, University of California Irvine, Irvine, CA, USA. Hauptthemen laut MEDLINE: Cachexia, Mathematical Concepts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Cancer Institute, Moffitt Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug dose response curves are ubiquitous in cancer biology, but these curves are often used to measure differential response in first-order effects: the effectiveness of increasing the cumulative dose delivered. In contrast, second-order effects (the variance of drug dose) are often ignored. Knowledge of second-order effects may improve the design of chemotherapy scheduling protocols, leading to improvements in tumor response without changing the total dose delivered. By considering treatment schedules with identical cumulative dose delivered, we characterize differential treatment outcomes resulting from high variance schedules (e.g. high dose, low dose) and low variance schedules (constant dose). We extend a previous framework used to quantify second-order effects, known as antifragility theory, to investigate the role of drug pharmacokinetics. Using a simple one-compartment model, we find that high variance schedules are effective for a wide range of cumulative dose values. Next, using a mouse-parameterized two-compartment model of 5-fluorouracil, we show that schedule viability depends on initial tumor volume. Finally, we illustrate the trade-off between tumor response and lean mass preservation. Mathematical modeling indicates that high variance dose schedules provide a potential path forward in mitigating the risk of chemotherapy-associated cachexia by preserving lean mass without sacrificing tumor response.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaMathematical ConceptsAnimalsAntineoplastic Combined Chemotherapy ProtocolsBiologyDisease Models, Animal

Stichwörter der Autor:innen

AntifragilityCachexiaDose response convexityPharmacodynamic modelingPharmacokinetic modeling

Autor:innen und Institutionen

  • Center for Complex Biological Systems, University of California Irvine, Irvine, CA, USA.
  • Department of Cancer Physiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, USA. alexander.anderson@moffitt.org.
  • Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, USA. jeffrey.west@moffitt.org.

ORCID-Profile: Jeffrey West

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Moffitt Cancer Center

Zitieren

APA

Pierik, L., McDonald, P., Anderson, A. R. A., & West, J. (2024). Second-Order Effects of Chemotherapy Pharmacodynamics and Pharmacokinetics on Tumor Regression and Cachexia. Bulletin of Mathematical Biology, 86(5). https://doi.org/10.1007/s11538-024-01278-0

Vancouver

Pierik L, McDonald P, Anderson ARA, West J. Second-Order Effects of Chemotherapy Pharmacodynamics and Pharmacokinetics on Tumor Regression and Cachexia. Bulletin of Mathematical Biology. 2024;86(5). doi:10.1007/s11538-024-01278-0

BibTeX
@article{Pierik2024,
  author = {Pierik, Luke and McDonald, Patricia and Anderson, Alexander R A and West, Jeffrey},
  title = {Second-Order Effects of Chemotherapy Pharmacodynamics and Pharmacokinetics on Tumor Regression and Cachexia},
  journal = {Bulletin of Mathematical Biology},
  year = {2024},
  volume = {86},
  number = {5},
  doi = {10.1007/s11538-024-01278-0}
}
Kostenlos starten →